G-BA godkender fire Long Covid-lægemidler til sygeforsikringsdækning

5. april 2026

Rapporteret af AI

Tysklands Gemeinsamer Bundesausschuss (G-BA) besluttede torsdag at give sygeforsikringer lov til at dække fire lægemidler, der lindrer visse Long Covid-symptomer. Tidligere skulle patienter selv betale for disse off-label anvendelser. Afgørelsen gør det lettere for landets 74 millioner lovpligtigt forsikrede at få adgang til behandlingen.

I Berlin udstedte G-BA, der regulerer ydelser for 74 millioner lovpligtigt sygeforsikrede, afgørelsen torsdag. Long Covid-patienter har stået over for høje omkostninger, da ingen lægemidler er officielt godkendt til tilstanden.

Martin Walter, klinikdirektør i Leipzig og leder af Post-Covid Task Force i det tyske selskab for psykiatri og psykoterapi, hilste beslutningen velkommen. "En situation, hvor intet enkelt lægemiddel hidtil havde været specifikt anbefalet, godkendt og refunderbart, selvom der forelå delvis international evidens og brug i andre lande," udtalte han til Science Media Center.

Walter fremhævede behovet: "Patienter behøver ikke længere ty til dyre, ikke-finansierede og uprøvede håndkøbspræparater." Tiltaget adresserer en central frustration i behandlingen af post-covid-gener.

Relaterede artikler

German cabinet meeting finalizing 2027 health reform draft with 16.3 billion euro savings target.

German government finalizes 2027 health reform draft with 16.3 billion euro savings target

28. april 2026 Rapporteret af AI Billede genereret af AI

Following Chancellor Merz's announcement that the bill was practically ready, the German government finalized its health reform draft on April 28, targeting 16.3 billion euros in savings from 2027—down from an initial 19.6 billion—to address a 15.3 billion euro deficit at statutory health insurers. The Greens decry it as a burden on insured people and companies, while Health Minister Nina Warken calls it balanced. Cabinet approval is set for Wednesday.

House doctors demand savings in health insurers' administrative costs

Markus Blumenthal-Beier, head of the German house doctors' association, calls on statutory health insurers to cut their administrative costs. He proposes halving them mid-term rather than restricting patient care. CSU politician Klaus Holetschek advises seeking cooperations and mergers.

KBV head Gassen calls specialist appointment guarantee „bullshit“

5. april 2026 Rapporteret af AI

Andreas Gassen, head of the Kassenärztliche Bundesvereinigung (KBV), dismissed demands for a guarantee of specialist doctor appointments within three weeks as „bullshit“ and „socialist regulatory frenzy“. He stressed that appointment allocations must be based on medical need. Gassen was responding to SPD parliamentary group leader Matthias Miersch.

Politik

Warken presents savings measures for statutory health insurance

Politik

Coalition dispute erupts over Warken's public health insurance savings draft

Politik

Chancellor Merz: Health reform bill practically ready for cabinet

End of reimbursement for sector 3 doctors' prescriptions in 2027

From January 1, 2027, prescriptions for care and medications by sector 3 liberal doctors will no longer be reimbursed by Assurance-maladie, under the 2026 social security financing law. The measure affects about 1,000 non-conventioned doctors out of more than 200,000 in practice. The profession is voicing anger over this restriction.